"Review Bombing Targets Copyright Accuser"

In a surprising twist, Schedule I, an indie game centered around the life of a dope pusher, finds itself at the center of a copyright infringement controversy. Movie Games S.A., the developers behind The Drug Dealer Simulator series, have accused Schedule I of breaching their intellectual property rights. According to a report from the Polish Press Agency dated April 3, Movie Games S.A. claims that Schedule I has replicated their games’ plot, mechanics, and user interface.

However, before any official verdict from the investigation, the gaming community has rallied in support of Schedule I. Fans have taken to Steam to express their discontent with Movie Games S.A., leading to a flood of negative reviews for The Drug Dealer Simulator and its sequel, now bearing the tags "Overwhelmingly Negative" and "Mostly Negative" respectively.

The backlash focuses on accusations of Movie Games S.A. unfairly targeting the indie developer, with some reviews highlighting the company's apparent hypocrisy. Critics point out that other similar games existed without any legal challenges until Schedule I's launch. This has stirred significant controversy, despite The Drug Dealer Simulator series being highly regarded in the criminal management genre.

Schedule I, which launched into Early Access on PC on March 25, offers players an immersive co-op crime simulation experience. Starting as a small-time dope pusher, players aim to ascend to the status of a kingpin. The game has garnered "Overwhelmingly Positive" reviews on Steam and currently ranks as the platform's 2nd top-selling game, surpassing well-known titles like inZOI, Monster Hunter Wilds, and R.E.P.O. SteamDB reports an all-time peak of 459,075 concurrent players for Schedule I.

At Game8, we found Schedule I to be a surprisingly engaging and rewarding game, earning it the nickname of a "Breaking Bad" simulator. For a deeper dive into our impressions of Schedule I during its Early Access phase, feel free to explore our detailed review below.